Literature DB >> 10407064

Elastase activated liposomal delivery to nucleated cells.

C C Pak1, R K Erukulla, P L Ahl, A S Janoff, P Meers.   

Abstract

The specific activation of liposomes for delivery has been explored by enzyme mediated cleavage of a peptide substrate covalently conjugated to a fusogenic lipid. We have previously shown an elastase sensitive peptide conjugated to 1, 2-dioleoyl-sn-glycero-3-phosphoethanolamine [corrected] (DOPE) could be activated by enzymatic cleavage, triggering liposome-liposome lipid mixing and fusion with erythrocyte ghosts (Pak et al., Biochim. Biophys. Acta, 1372 (1998) 13-27). Further optimization of this system has been aimed at obtaining substrate cleavage at or below physiological elastase levels and to demonstrate triggered delivery to living cells. Therefore a new peptide-lipid, MeO-suc-AAPV-DOPE (N-methoxy-succinyl-Ala-Ala-Pro-Val-DOPE), has been developed that exhibits greater sensitivity and selectivity for elastase cleavage and subsequent conversion to DOPE. This peptide-lipid was used with DODAP (dioleoyl dimethylammonium propane, a pH dependent cationic lipid) in a 1:1 mol ratio with the expectation that endocytosis would lead to a liposome with an overall positive charge if enzymatic cleavage had occurred. Elastase treated liposomes displayed pH dependent enhancement of binding, lipid mixing, and delivery of 10000 MW dextrans, relative to untreated liposomes, when incubated with HL60 human leukemic cells. Heat denatured elastase did not activate DODAP/MeO-suc-AAPV-DOPE liposomes, indicating enzymatic activity of elastase is necessary. Liposomes bound to ECV304 endothelial cells at physiological pH could be activated by elastase to deliver an encapsulated fluorescent probe, calcein, into the cell cytoplasm. These results suggest enzyme substrate peptides linked to a fusogenic lipid may be used to elicit specific delivery from liposomes to cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407064     DOI: 10.1016/s0005-2736(98)00256-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.

Authors:  Mary Caldorera-Moore; Nathalie Guimard; Li Shi; Krishnendu Roy
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

2.  Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound.

Authors:  Ayele H Negussie; Pavel S Yarmolenko; Ari Partanen; Ashish Ranjan; Genevieve Jacobs; David Woods; Henry Bryant; David Thomasson; Mark W Dewhirst; Bradford J Wood; Matthew R Dreher
Journal:  Int J Hyperthermia       Date:  2011       Impact factor: 3.914

Review 3.  siRNA Delivery by Stimuli-Sensitive Nanocarriers.

Authors:  Giuseppina Salzano; Daniel F Costa; Vladimir P Torchilin
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 4.  Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.

Authors:  Thomas L Andresen; David H Thompson; Thomas Kaasgaard
Journal:  Mol Membr Biol       Date:  2010-10-13       Impact factor: 2.857

Review 5.  In vivo gene delivery by nonviral vectors: overcoming hurdles?

Authors:  Yuan Zhang; Andrew Satterlee; Leaf Huang
Journal:  Mol Ther       Date:  2012-04-24       Impact factor: 11.454

Review 6.  Design properties of hydrogel tissue-engineering scaffolds.

Authors:  Junmin Zhu; Roger E Marchant
Journal:  Expert Rev Med Devices       Date:  2011-09       Impact factor: 3.166

Review 7.  Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs.

Authors:  Farnaz Fouladi; Kristine J Steffen; Sanku Mallik
Journal:  Bioconjug Chem       Date:  2017-03-08       Impact factor: 4.774

Review 8.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

9.  Human neutrophil elastase responsive delivery from poly(ethylene glycol) hydrogels.

Authors:  Alex A Aimetti; Mark W Tibbitt; Kristi S Anseth
Journal:  Biomacromolecules       Date:  2009-06-08       Impact factor: 6.988

10.  Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA.

Authors:  Peerada Yingyuad; Mathieu Mével; Carla Prata; Christos Kontogiorgis; Maya Thanou; Andrew D Miller
Journal:  J RNAi Gene Silencing       Date:  2014-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.